Related references
Note: Only part of the references are listed.Prognostic Value of Soluble Suppression of Tumorigenicity 2 in Chronic Kidney Disease Patients: A Meta-Analysis
Guangying Guo et al.
DISEASE MARKERS (2021)
Circulating heart failure biomarkers beyond natriuretic peptides: review from the Biomarker Study Group of the Heart Failure Association (HFA), European Society of Cardiology (ESC)
Wouter C. Meijers et al.
EUROPEAN JOURNAL OF HEART FAILURE (2021)
Superior prognostic value of soluble suppression of tumorigenicity 2 for the short-term mortality of maintenance hemodialysis patients compared with NT-proBNP: a prospective cohort study
Zhiyu Wang et al.
RENAL FAILURE (2020)
US Renal Data System 2017 Annual Data Report Epidemiology of Kidney Disease in the United States
Rajiv Saran et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2018)
GDF-15, Galectin 3, Soluble ST2, and Risk of Mortality and Cardiovascular Events in CKD
Courtney Tuegel et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2018)
Independent Prognostic Value of Serum Soluble ST2 Measurements in Patients With Heart Failure and a Reduced Ejection Fraction in the PARADIGM-HF Trial (Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure)
Eileen O'Meara et al.
CIRCULATION-HEART FAILURE (2018)
ST2 as a novel prognostic marker in end-stage renal disease patients on hemodiafiltration
Evgenija Homsak et al.
CLINICA CHIMICA ACTA (2018)
Predictive value of low interleukin-33 in critically ill patients
Konstantin A. Krychtiuk et al.
CYTOKINE (2018)
Biomarkers as predictors of sudden cardiac death in coronary artery disease patients with preserved left ventricular function (ARTEMIS study)
E. Samuli Lepojarvi et al.
PLOS ONE (2018)
sST2 Predicts Outcome in Chronic Heart Failure Beyond N-proBNP and High-Sensitivity Troponin T
Michele Emdin et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Increased Soluble Suppression of Tumorigenicity 2 Level Predicts All-Cause and Cardiovascular Mortality in Maintenance Hemodialysis Patients: A Prospective Cohort Study
Zhen Zhang et al.
BLOOD PURIFICATION (2017)
Ablation of IL-33 gene exacerbate myocardial remodeling in mice with heart failure induced by mechanical stress
Punniyakoti T. Veeraveedu et al.
BIOCHEMICAL PHARMACOLOGY (2017)
Increased Plasma Concentrations of Soluble ST2 Independently Predict Mortality but not Cardiovascular Events in Stable Coronary Heart Disease Patients: 13-Year Follow-up of the KAROLA Study
Vanessa Pfetsch et al.
CARDIOVASCULAR DRUGS AND THERAPY (2017)
Independent and incremental prognostic value of novel cardiac biomarkers in chronic hemodialysis patients
Masaru Obokata et al.
AMERICAN HEART JOURNAL (2016)
Impact of diabetes on the predictive value of heart failure biomarkers
Nuria Alonso et al.
CARDIOVASCULAR DIABETOLOGY (2016)
Interleukin-33 facilitates neutrophil recruitment and bacterial clearance in S-aureus-caused peritonitis
Fang Lan et al.
MOLECULAR IMMUNOLOGY (2016)
The Biology of ST2: The International ST2 Consensus Panel
Domingo A. Pascual-Figal et al.
AMERICAN JOURNAL OF CARDIOLOGY (2015)
Plasma concentrations of novel cardiac biomarkers before and after hemodialysis session
Thomas Mueller et al.
CLINICAL BIOCHEMISTRY (2015)
The IL-33/ST2 axis: Role in health and disease
Marjorie De la Fuente et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2015)
Crucial and Diverse Role of the Interleukin-33/ST2 Axis in Infectious Diseases
Octavie Rostan et al.
INFECTION AND IMMUNITY (2015)
Myocardial pressure overload induces systemic inflammation through endothelial cell IL-33
Wei-Yu Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Increased Soluble ST2 Predicts Long-term Mortality in Patients with Stable Coronary Artery Disease: Results from the Ludwigshafen Risk and Cardiovascular Health Study
Benjamin Dieplinger et al.
CLINICAL CHEMISTRY (2014)
ST2 may not be a useful predictor for incident cardiovascular events, heart failure and mortality
Maria F. Hughes et al.
HEART (2014)
Head-to-Head Comparison of Serial Soluble ST2, Growth Differentiation Factor-15, and Highly-Sensitive Troponin T Measurements in Patients With Chronic Heart Failure
Hanna K. Gaggin et al.
JACC-HEART FAILURE (2014)
Biological variation of galectin-3 and soluble ST2 for chronic heart failure: Implication on interpretation of test results
Alan H. B. Wu et al.
AMERICAN HEART JOURNAL (2013)
Components of the interleukin-33/ST2 system are differentially expressed and regulated in human cardiac cells and in cells of the cardiac vasculature
Svitlana Demyanets et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2013)
Prognostic Utility of Novel Biomarkers of Cardiovascular Stress The Framingham Heart Study
Thomas J. Wang et al.
CIRCULATION (2012)
Distribution and Clinical Correlates of the Interleukin Receptor Family Member Soluble ST2 in the Framingham Heart Study
Erin E. Coglianese et al.
CLINICAL CHEMISTRY (2012)
Combined use of high-sensitivity ST2 and NTproBNP to improve the prediction of death in heart failure
Antoni Bayes-Genis et al.
EUROPEAN JOURNAL OF HEART FAILURE (2012)
High-Sensitivity ST2 for Prediction of Adverse Outcomes in Chronic Heart Failure
Bonnie Ky et al.
CIRCULATION-HEART FAILURE (2011)
Role of IL-33 in inflammation and disease
Ashley M. Miller
JOURNAL OF INFLAMMATION-LONDON (2011)
Soluble ST2 plasma concentrations predict mortality in severe sepsis
Jacobien J. Hoogerwerf et al.
INTENSIVE CARE MEDICINE (2010)
IL-33 Reduces Macrophage Foam Cell Formation
James E. McLaren et al.
JOURNAL OF IMMUNOLOGY (2010)
Serum Soluble ST2 A Potential Novel Mediator in Left Ventricular and Infarct Remodeling After Acute Myocardial Infarction
Robin A. P. Weir et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection
Jose C. Alves-Filho et al.
NATURE MEDICINE (2010)
Interleukin-33 Prevents Apoptosis and Improves Survival After Experimental Myocardial Infarction Through ST2 Signaling
Kenjiro Seki et al.
CIRCULATION-HEART FAILURE (2009)
Analytical and clinical evaluation of a novel high-sensitivity assay for measurement of soluble ST2 in human plasma - The Presage™ ST2 assay
Benjamin Dieplinger et al.
CLINICA CHIMICA ACTA (2009)
Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction
Marc S. Sabatine et al.
CIRCULATION (2008)
Increased plasma concentrations of soluble ST2 are predictive for 1-year mortality in patients with acute destabilized heart failure
Thomas Mueller et al.
CLINICAL CHEMISTRY (2008)
IL-33 reduces the development of atherosclerosis
Ashley M. Miller et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Characteristics of the Novel Interleukin Family Biomarker ST2 in Patients With Acute Heart Failure
Shafiq U. Rehman et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
IL-33 and ST2 comprise a critical biomechanically induced and card ioprotective signaling system
Shoji Sanada et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis
C Wanner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction
M Shimpo et al.
CIRCULATION (2004)
Identification of serum soluble ST2 receptor as a novel heart failure biomarker
EO Weinberg et al.
CIRCULATION (2003)
Share Paper
